Abstract Views :330 |
PDF Views:0
Authors
Affiliations
1 Department of Medicine, SDM College of
Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, IN
Source
International Journal of Contemporary Medicine, Vol 1, No 2 (2013), Pagination: 18-20
Abstract
Kikuchi-Fujimoto disease (KFD) or histiocytic necrotizing lymphadenitis is a rare benign, self-limiting cervical lymphadenitis of unknown etiology. It predominantly affects young women and can closely mimic infective and immunological disorders. We report a case of Kikuchi-Fujimoto disease in a 40 year old male who presented with fever and cervical lymphadenitis.
Keywords
Kikuchi-Fujimoto Disease, Histiocytic Necrotizing Lymphadenitis.
References
- Safaa AlKhawaja, Khatoon Ali, Shameem Shareef. Kikuchi’s disease. Bahrain Med Bull 2006; 28(3): 1-6.
- Sudhakar MK, Sathyamurthy P, Indhumathi E, Amarabalan Rajendran, Bavya Vivek. Kikuchi’s disease: A case report from south India. IJCRI 2011; 2(2):15-18.
- Dorfman RF, Berry GJ. Kikuchi’s histiocytic necrotizing lymphadenitis: An analysis of 108 cases with emphasis on differential diagnosis. Semin Diagn Pathol 1988; 5: 329-45.
- Mugnaini EN, Watson T, Guccion J, Benator D. Kikuchi disease presenting as a flu-like illness with rash and lymphadenopathy. Am J Med Sci. 2003;325 (1):34-7.
- Xavier Bosch, Antonio Guilabert. Kikuchi- Fujimoto disease. OJRD 2006;1: 1-18.
- Sousa Ade A, Soares JM, de Sa Santos MH, Martins MP, Salles JM. Kikuchi-Fujimoto disease: three case reports. Sao Paulo Med J. 2010; 128(4):232-235.
- Tsang WYW, Chan JKC, Ng CS. Kikuchi’s lymphadenitis – a morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol1994; 18: 219-231.
- Louis N, Hanley M, Davidson NM. Kikuchi– Fujimoto disease: a report of two cases and an overview. J Laryngol Otol 1994; 108: 1001-04.
- Jang YJ, Park KH, Seok HJ. Management of Kikuchi’s disease using glucocorticoid. J Laryngol Otol 2000; 114: 709-11.
- Noursadeghi M, Aqel N, Gibson P, Pasvol G. Successful treatment of severe Kikuchi’s disease with intravenous immunoglobulin Rheumatology 2005; 45: 235-37.
